Ken Banta and Andrew Hall share insights on leading through uncertainty—covering culture, capital, risk, and the regulatory headwinds influencing key decisions in drug development.
Ken Banta
Advertisement
Founder and CEO of The Vanguard Network, a membership organization that supports and advises CEOs and their senior teams. Banta is former head of strategic affairs at Schering-Plough, Bausch & Lomb, and Pharmacia and helped lead 11 global turnarounds, mergers, and transformations. He began his career as a correspondent/writer with Time Magazine, including as Eastern Europe bureau chief covering the fall of communism and the democratic revolutions of the region.
Banta is the author of “Seeing Around Corners”: C-Suite wisdom from America’s most insightful leaders.
Articles by Ken Banta
A case study in leading and guiding a cultural reset and strategic revival.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5